Next Article in Journal
Occurrence of Surgical Site Infections at a Tertiary Healthcare Facility in Abuja, Nigeria: A Prospective Observational Study
Next Article in Special Issue
Cell Therapy in Idiopathic Pulmonary Fibrosis
Previous Article in Journal / Special Issue
Causes of Pulmonary Fibrosis in the Elderly
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessReview
Med. Sci. 2018, 6(3), 59; https://doi.org/10.3390/medsci6030059

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis

Department of Respiratory Medicine, Hospital de la Santa Creu I Sant Pau, C/Sant Antoni M. Claret, 167, 08025 Barcelona, Spain
*
Author to whom correspondence should be addressed.
Received: 11 June 2018 / Revised: 11 July 2018 / Accepted: 17 July 2018 / Published: 24 July 2018
(This article belongs to the Special Issue Idiopathic Pulmonary Fibrosis)
Full-Text   |   PDF [1002 KB, uploaded 24 July 2018]   |  
  |   Review Reports

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease. The treatment is challenging and nowadays a comprehensive approach based not only in pharmacological strategies is necessary. Identification and control of comorbidities, non-pharmacological treatment, prevention and management of exacerbations as well as other areas of care (social, psychological) are fundamental for a holistic management of IPF. Gastroesophageal reflux, pulmonary hypertension, obstructive sleep apnea, combined with emphysema, lung cancer and cardiovascular involvement are the main comorbidities associated with IPF. Non-pharmacological treatment includes the use of oxygen in patients with rest or nocturnal hypoxemia and other support therapies such as non-invasive ventilation or even a high-flow nasal cannula to improve dyspnea. In some patients, lung transplant should be considered as this enhances survival. Pulmonary rehabilitation can add benefits in outcomes such control of dyspnea, exercise capacity distance and, overall, improve the quality of life; therefore it should be considered in patients with IPF. Also, multidisciplinary palliative care programs could help with symptom control and psychological support, with the aim of maintaining quality of life during the whole process of the disease. This review intends to provide clear information to help those involved in IPF follow up to improve patients’ daily care. View Full-Text
Keywords: idiopathic pulmonary fibrosis; palliative care; comorbidities; pulmonary rehabilitation; ambulatory oxygen therapy idiopathic pulmonary fibrosis; palliative care; comorbidities; pulmonary rehabilitation; ambulatory oxygen therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Millan-Billi, P.; Serra, C.; Alonso Leon, A.; Castillo, D. Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis. Med. Sci. 2018, 6, 59.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Med. Sci. EISSN 2076-3271 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top